Home » Topics » Conferences

Conferences
RSS

Yamanouchi describes AMPA antagonists for stroke

Sep. 27, 1996

Novel antiemetic/gastric prokinetic agent from Dainippon

Sep. 27, 1996

New anxiolytic from SmithKline Beecham

Sep. 27, 1996

Hypocholesterolemic and hypocholesterolemic/antioxidant compounds from Pierre Fabre

Sep. 27, 1996

Immunosuppressant oligopeptide from Italfarmaco

Sep. 27, 1996

Development of COX-2 inhibitors at Searle

Sep. 27, 1996

Ciba characterizes another novel HIV protease inhibitor

Sep. 27, 1996

Novel class of HIV protease inhibitors with improved activity

Sep. 27, 1996

New antiinfluenza virus agent reported by Gilead Sciences

Sep. 27, 1996

Novel antifungal antibiotic reported by German and Swedish researchers

Sep. 27, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 17, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 17, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.